Naringenin derivatives as glucosamine-6-phosphate synthase inhibitors: synthesis, antioxidants, antimicrobial, preservative efficacy, molecular docking and in silico ADMET analysis

Table 3 Log CFU/mL values of the selected compound 1

Compound(s)	E. coli		P. aeruginosa		S. aureus		C. albicans		A. niger
CFU/mL after days	14 days	28 days	14 days	28 days	14 days	28 days	14 days	28 days	14 days	28 days
Compound 1	3.190 ± 0.008	3.496 ± 0.12	3.306 ± 0.16	3.406 ± 0.016	3.486 ± 0.012	3.486 ± 0.012	3.200 ± 0.081	3.313 ± 0.016	3.306 ± 0.016	3.463 ± 0.020
Sodium Benzoate	3.213 ± 0.012	3.323 ± 0.24	3.282 ± 016	3.210 ± 0.037	3.863 ± 0.044	3.166 ± 0.047	3.076 ± 0.088	2.800 ± 0.081	3.166 ± 0.012	3.320 ± 0.014
Propyl Paraben	3.280 ± 0.57	3.246 ± 0.36	3.310 ± 0.016	3.306 ± 0.016	3.883 ± 0.023	3.516 ± 0.012	3.940 ± 0.028	3.530 ± 0.016	3.113 ± 0.065	3.403 ± 0.012
Ethyl Paraben	3.336 ± 0.020	3.090 ± 0.148	3.246 ± 0.36	3.340 ± 0.014	3.166 ± 0.047	3.210 ± 0.008	3.520 ± 0.014	3.200 ± 0.018	3.043 ± 0.041	3.300 ± 0.081

ISSN: 2661-801X